Authorized purpose: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.
Clinical role
Cloud-processed caries detection and localization as a second reader, with editable findings rendered in the client interface; final diagnosis and treatment decisions remain with the dentist.
Images and patients
X-ray/Radiography · Dental/Maxillofacial
Key limitation
Keep in mind: Exact K242522 labeling is limited to caries contouring on bitewing and periapical permanent-tooth radiographs for patients 19 years or older. It does not establish panoramic use or detection of the broader findings advertised for the current Second Opinion family. False positives and false negatives remain possible, and a complete dentist review is required.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Dental/Maxillofacial Input: Digital intraoral bitewing and periapical radiographs of permanent teeth in patients aged 19 years or older, sent through the application programming interface for cloud processing.
Who uses it?Intended users: Dental health professionals, including dentists, who review the radiograph, image findings, patient history, and in-vivo clinical assessment.
What does the software produce?Output: Machine-generated detection metadata rendered as editable polygonal overlays on the original radiograph to identify teeth and suspected carious lesions requiring clinical review.
What is its most important limitation?Key limitation: Exact K242522 labeling is limited to caries contouring on bitewing and periapical permanent-tooth radiographs for patients 19 years or older. It does not establish panoramic use or detection of the broader findings advertised for the current Second Opinion family. False positives and false negatives remain possible, and a complete dentist review is required.
Clinical takeaway. Clinical role: Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.
Evidence takeaway. Evidence from the reviewed source record: K242522's 500-image standalone comparison evaluates caries localization by polygon contours versus the predicate's bounding boxes. Endpoint definitions, image mix, lesion count, and false-positive burden are retained so the 90% sensitivity is not interpreted in isolation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Second Opinion CC assists dental health professionals as a second reader for caries on bitewing and periapical radiographs of permanent teeth in patients 19 years or older, displaying editable polygonal contours for clinician review; it does not replace a complete dentist review or clinical judgment.
Cloud-processed caries detection and localization as a second reader, with editable findings rendered in the client interface; final diagnosis and treatment decisions remain with the dentist.
Digital intraoral bitewing and periapical radiographs of permanent teeth in patients aged 19 years or older, sent through the application programming interface for cloud processing.
Machine-generated detection metadata rendered as editable polygonal overlays on the original radiograph to identify teeth and suspected carious lesions requiring clinical review.
Exact K242522 labeling is limited to caries contouring on bitewing and periapical permanent-tooth radiographs for patients 19 years or older. It does not establish panoramic use or detection of the broader findings advertised for the current Second Opinion family. False positives and false negatives remain possible, and a complete dentist review is required.
K242522's 500-image standalone comparison evaluates caries localization by polygon contours versus the predicate's bounding boxes. Endpoint definitions, image mix, lesion count, and false-positive burden are retained so the 90% sensitivity is not interpreted in isolation.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K242522's 500-image standalone comparison evaluates caries localization by polygon contours versus the predicate's bounding boxes. Endpoint definitions, image mix, lesion count, and false-positive burden are retained so the 90% sensitivity is not interpreted in isolation.
K242522 Second Opinion CC standalone non-inferiority study
DesignStandalone non-inferiority comparison of polygonal Second Opinion CC with the bounding-box Second Opinion predicate using four-reader consensus ground truth and wAFROC as the primary efficacy paradigm.
Population500 images: 249 periapical and 251 bitewing; 212 caries-positive images with 356 lesions. The age metadata included 9 images from ages 12-18, 233 from ages 18-75, 13 from ages 75+, and 245 with unknown age despite labeling for patients 19 years or older.
Scopeexact submission
Tested versionSecond Opinion CC caries-contouring configuration described in K242522
Samplen=500
IndependenceSponsor or vendor study
K242522
Manufacturer-submitted regulatory evidence. The age-distribution mismatch and large unknown-age share should be addressed during local evidence review; the FDA summary does not provide a subgroup result for the labeled 19+ population.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-submission FDA recall query returned no native recall record for K242522. This limited query does not establish absence of recalls or other safety information.
Pearl states in a patient-facing article that AI analysis is typically incorporated into routine dental diagnostic care and not billed separately; this is a vendor generalization, not an exact-product payer policy or coverage determination.
General dental insurance context stated by Pearl · United States
Do not infer reimbursement, patient cost, or contract pricing. Verify each payer, plan, underlying exam/X-ray benefit, provider agreement, and billing practice.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Digital intraoral bitewing and periapical radiographs of permanent teeth in patients aged 19 years or older, sent through the application programming interface for cloud processing.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact device contains an API, machine-learning modules, and a client interface: images and metadata pass through the API to cloud-based processing and detections return as metadata for interface rendering. Exact connectors and supported practice systems are not listed in the FDA summary.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Cloud-based processing with a Windows client environment, as described in the exact FDA substantial-equivalence comparison.
Scope: Exact FDA submission. Current hosting region, tenancy, retention, service levels, and exact client requirements require vendor confirmation.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Machine-generated detection metadata rendered as editable polygonal overlays on the original radiograph to identify teeth and suspected carious lesions requiring clinical review.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Machine-generated detection metadata rendered as editable polygonal overlays on the original radiograph to identify teeth and suspected carious lesions requiring clinical review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact device contains an API, machine-learning modules, and a client interface: images and metadata pass through the API to cloud-based processing and detections return as metadata for interface rendering. Exact connectors and supported practice systems are not listed in the FDA summary.
The exact FDA summary states that Pearl developed security controls and development/postmarket processes using the FDA's September 2023 premarket cybersecurity guidance and December 2016 postmarket cybersecurity guidance. It does not disclose the control scope, audit evidence, data flow, retention, or assurance period needed for procurement.
The exact submission describes an API that routes image data to cloud machine-learning modules and returns detection metadata to a Windows client for editable polygon rendering.
Pearl's current Second Opinion page describes native integrations with more than 40 imaging and practice-management systems plus a standalone web app, with vendor-led setup. This is family context and does not establish connector or feature availability for the exact K242522 configuration.
Pearl's current page says most current-family images load in under one minute and includes bitewing, periapical, and panoramic workflows across many findings. Only the exact K242522 caries, bitewing/periapical, permanent-teeth, and age-19+ scope is applicable to this dossier.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-08Last searched
25Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored PubMed and ClinicalTrials.gov candidate arrays were empty. No paper or trial was promoted; empty arrays do not establish absence of external evidence. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor patient education, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-08 - Exact FDA submission
No public exact-product amount, pricing unit, term, minimum, implementation fee, or support inclusion was established.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
Pearl's patient-facing blog says AI is typically not separately billed, but it is not payer policy and does not establish product reimbursement or underlying-service coverage.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Role-based onboarding, clinical-use training, competency assessment, support terms, and retraining after updates were not established.
Authorized purpose: Analyzes bitewing, periapical, and panoramic intraoral radiographs from patients aged 3 years and older to identify and localize specified suspected dental findings, historical treatments, and normal anatomy; diagnostic use remains with trained dental professionals.
Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.
Authorized purpose: Provides automated concurrent-read detection and segmentation of caries on bitewing radiographs in patients 18 and older, adding information for the dentist while requiring complete dentist review and judgment.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.